Shares of Bausch up 7% after company gives rosier full-year guidance
May 06, 2019 at 11:39 AM EDT
Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, raised its full-year outlook on Monday, after reporting first-quarter revenue that missed expectations.
